Euglobulin fibrinolytic activity in NIDDM patients

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Hematology

Background:

• Fibrinolytic activity, crucial for blood clot breakdown, may be altered in diabetes mellitus.
• Diabetic retinopathy is a significant complication of diabetes, and its pathogenesis is not fully understood.

Purpose of the Study:

• To investigate euglobulin fibrinolytic activity in non-insulin-dependent diabetics compared to healthy controls.
• To explore the relationship between fibrinolytic activity and the presence and severity of diabetic retinopathy.

Main Methods:

• Euglobulin fibrinolytic activity was measured in 56 non-insulin-dependent diabetics and 118 controls.
• Measurements were taken before and after venous occlusion to assess basal and stimulated fibrinolysis.
• Correlations with diabetes duration, obesity, glycemic control (HbA1c), and proteinuria were examined.

Main Results:

• Basal and stimulated fibrinolytic activity were significantly impaired in diabetics compared to controls.
• No correlation was found between fibrinolytic activity and age, diabetes duration, obesity, triglycerides, HbA1c, or proteinuria.
• Fibrinolytic activity was lower in diabetics with retinopathy than in those without.
• Diabetics with long-standing diabetes and no retinopathy had higher fibrinolytic activity than those with shorter diabetes duration and retinopathy.

Conclusions:

• Impaired fibrinolytic activity is associated with diabetic retinopathy, suggesting a potential role in its development.
• Fibrinolysis may be a contributing factor to microvascular complications in diabetes, specifically retinopathy.
• Targeting fibrinolytic pathways could be a future therapeutic strategy for preventing or treating diabetic retinopathy.